Skip to content

Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients

Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00002052
Enrollment
Unknown
Registered
2001-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2005-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections, Salmonella Infections

Keywords

Salmonella Infections, AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Amoxicillin, Ceftriaxone

Brief summary

To compare the effectiveness of standard treatment with parenteral ampicillin and oral amoxicillin compared to initial daily therapy with ceftriaxone followed by 3 times weekly suppressive treatment for salmonella infections in AIDS patients.

Interventions

Sponsors

University of Southern California
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Exclusion criteria

Co-existing Condition: Patients with the following are excluded: * Type I hypersensitivity to beta-lactam antibiotics. * Not expected to survive 12 weeks. * In a coma or with other central nervous system (CNS) impairment. Patients with the following are excluded: * Type I hypersensitivity to beta-lactam antibiotics. * Not expected to survive 12 weeks. * In a coma or with other central nervous system (CNS) impairment. Prior Medication: Excluded within 48 hours of study entry: * Treatment with an antibiotic active in vitro against Salmonella. HIV infection, AIDS, or AIDS related complex (ARC). * Salmonella bacteremia or positive stool culture in patient with 3 or more stools per day.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026